Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Calderón-Goercke M
  • Castañeda S
  • Aldasoro V
  • Villa I
  • Prieto-Peña D
  • Atienza-Mateo B
  • Patiño E
  • Moriano C
  • Romero-Yuste S
  • Narváez J
  • Gómez-Arango C
  • Pérez-Pampín E
  • Melero R
  • Becerra-Fernández E
  • Revenga M
  • Álvarez-Rivas N
  • Galisteo C
  • Sivera F
  • Olivé-Marqués A
  • Álvarez Del Buergo M
  • Marena-Rojas L
  • Fernández-López C
  • Navarro F
  • Raya E
  • Galindez-Agirregoikoa E
  • Arca B
  • Solans-Laqué R
  • Conesa A
  • Hidalgo C
  • Vázquez C
  • Loricera J
  • Lluch P
  • Manrique-Arija S
  • Vela P
  • De Miguel E
  • Torres-Martín C
  • Nieto JC
  • Ordas-Calvo C
  • Salgado-Pérez E
  • Luna-Gomez C
  • Toyos-Sáenz de Miera FJ
  • Fernández-Llanio N
  • García A
  • Larena C
  • González-Vela C
  • Corrales A
  • Varela-García M
  • Aurrecoechea E
  • Dos Santos R
  • García-Manzanares Á
  • Ortego N
  • Fernández S
  • Corteguera M
  • Hernández JL
  • González-Gay MÁ
  • Blanco R

Grupos

Abstract

A potential point of concern among clinicians is whether results derived from the clinical trials can be reasonably applied or generalised to a definable group of patients seen in real world. It can be the case of the GiACTA study that is a phase III randomised controlled trial of tocilizumab (TCZ) in giant cell arteritis (GCA). To address this question, we compared the clinical features and the responses to TCZ from the GiACTA trial patients with those from a series of GCA seen in the daily clinical practice.

Datos de la publicación

ISSN/ISSNe:
0392-856X, 1593-098X

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY  CLINICAL & EXPER RHEUMATOLOGY

Tipo:
Article
Páginas:
112-119
DOI:
PubMed:
32441643
Factor de Impacto:
1,184 SCImago ℠
Cuartil:
Q2 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Campos de Estudio

Compartir